1. Retraction Note to: Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer

   • Haifeng Zong
   • Yang Zhang
   • Yehuang Wang

   Retraction Note 22 September 2015 Article: 243

2. Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial

   • Sebastian Ochenduszko
   • Miroslawa Puskulluoglu
   • Krzysztof Krzemieniecki

   Original Paper Open access 09 September 2015 Article: 242

   

3. A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer

   • Ming Cui
   • Ziyu Li
   • Xiangqian Su

   Original Paper 08 September 2015 Article: 241

   

4. Efficacy and safety of pirarubicin plus capecitabine versus pirarubicin plus cyclophosphamide in Chinese node-negative breast cancer patients: a 4-year open-label, randomized, controlled study

   • Xiaohui Zhang
   • Yidong Zhou
   • Qiang Sun

   Original Paper 07 September 2015 Article: 240

   

5. TRAF6 is required for BLyS-mediated NF-κB signaling in multiple myeloma cells

   • Xinfeng Wang
   • Jingjing Wang
   • Hongming Huang

   Original Paper 03 September 2015 Article: 239

   

6. Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma

   • Jianhua Li
   • Xinguang Qiu
   • Shuijun Zhang

   Original Paper 02 September 2015 Article: 238

   

7. Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation?

   • Giovanna E. Carpagnano
   • Donato Lacedonia
   • Maria P. Foschino-Barbaro

   Original Paper 01 September 2015 Article: 237

8. Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia

   • Gilles Freyer
   • Ewa Kalinka-Warzocha
   • Zsolt Szabo

   Original Paper 28 August 2015 Article: 236

   

9. Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer

   • Yasuyoshi Miyata
   • Akihiro Asai
   • Hideki Sakai

   Original Paper Open access 27 August 2015 Article: 235